Skip to main content
Log in

Family history of malignant and benign thyroid diseases and risk of thyroid cancer: a population-based case–control study in New Caledonia

  • Original paper
  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

Purpose

Exceptionally high incidence rates of thyroid cancer have been observed in New Caledonia, particularly in Melanesian women, but familial aggregation of thyroid diseases in this population is unknown. We study the association between family history of malignant or benign thyroid diseases and non-medullary thyroid cancer in this country.

Methods

We conducted a population-based case–control study including 332 cases with papillary or follicular carcinoma diagnosed in 1993–1999 and 412 controls, matched by sex and 5-year age-group.

Results

Thyroid cancer was associated with a history of thyroid cancer in first-degree relatives (odds ratio (OR), 3.2; 95 % CI, 1.6–6.2) and with a family history of multinodular goiter (OR, 3.6; 95 % CI, 1.9–7.0). The ORs did not change by age at diagnosis and with the number of affected relatives. The study provides evidence that the familial component of thyroid cancer is particularly strong in men. Thyroid cancer was not associated with a family history of thyroid diseases in Melanesians from the Loyalty Islands, the area with the highest incidence rates for thyroid cancer, possibly indicating a high frequency of genetic susceptibility variants and lack of genetic variation in this population subgroup.

Conclusion

Overall our findings confirm an elevated risk of thyroid cancer in individuals with a family history of malignant or benign thyroid diseases, particularly in Melanesians where familial aggregation of thyroid cancer had never been investigated before. The study of genetic variants in candidate susceptibility genes for thyroid cancer may help clarifying the absence of an association in the subgroup of Melanesians from the Loyalty Islands.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

CI:

Confidence interval

FRR:

Familial relative risk

OR:

Odds ratio

NMTC:

Non-medullary thyroid cancer

SIR:

Standardized incidence ratio

References

  1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12):2893–2917

    Article  PubMed  CAS  Google Scholar 

  2. Ferlay J, Parkin DM, Steliarova-Foucher E (2010) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46(4):765–781

    Article  PubMed  CAS  Google Scholar 

  3. Cancer incidence in five continents, vol VIII. IARC Science Publication no. 155, pp 1–781 (2002)

  4. Kent WD, Hall SF, Isotalo PA, Houlden RL, George RL, Groome PA (2007) Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease. CMAJ 177(11):1357–1361

    Article  PubMed  Google Scholar 

  5. Liu S, Semenciw R, Ugnat AM, Mao Y (2001) Increasing thyroid cancer incidence in Canada, 1970–1996: time trends and age-period-cohort effects. Br J Cancer 85(9):1335–1339

    Article  PubMed  CAS  Google Scholar 

  6. Zheng T, Holford TR, Chen Y, Ma JZ, Flannery J, Liu W et al (1996) Time trend and age-period-cohort effect on incidence of thyroid cancer in Connecticut, 1935–1992. Int J Cancer 67(4):504–509

    Article  PubMed  CAS  Google Scholar 

  7. Davies L, Welch HG (2006) Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 295(18):2164–2167

    Article  PubMed  CAS  Google Scholar 

  8. Smailyte G, Miseikyte-Kaubriene E, Kurtinaitis J (2006) Increasing thyroid cancer incidence in Lithuania in 1978–2003. BMC Cancer 6:284

    Article  PubMed  Google Scholar 

  9. Reynolds RM, Weir J, Stockton DL, Brewster DH, Sandeep TC, Strachan MW (2005) Changing trends in incidence and mortality of thyroid cancer in Scotland. Clin Endocrinol (Oxf) 62(2):156–162

    Article  Google Scholar 

  10. Colonna M, Guizard AV, Schvartz C, Velten M, Raverdy N, Molinie F et al (2007) A time trend analysis of papillary and follicular cancers as a function of tumour size: a study of data from six cancer registries in France (1983–2000). Eur J Cancer 43(5):891–900

    Article  PubMed  CAS  Google Scholar 

  11. Burgess JR, Tucker P (2006) Incidence trends for papillary thyroid carcinoma and their correlation with thyroid surgery and thyroid fine-needle aspirate cytology. Thyroid 16(1):47–53

    Article  PubMed  Google Scholar 

  12. Leenhardt L, Grosclaude P, Cherie-Challine L (2004) Increased incidence of thyroid carcinoma in France: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee. Thyroid 14(12):1056–1060

    Article  PubMed  Google Scholar 

  13. Yu GP, Li JC, Branovan D, McCormick S, Schantz SP (2010) Thyroid cancer incidence and survival in the national cancer institute surveillance, epidemiology, and end results race/ethnicity groups. Thyroid 20(5):465–473

    Article  PubMed  Google Scholar 

  14. Enewold L, Zhu K, Ron E, Marrogi AJ, Stojadinovic A, Peoples GE et al (2009) Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980–2005. Cancer Epidemiol Biomarkers Prev 18(3):784–791

    Article  PubMed  Google Scholar 

  15. Truong T, Rougier Y, Dubourdieu D, Guihenneuc-Jouyaux C, Orsi L, Hemon D et al (2007) Time trends and geographic variations for thyroid cancer in New Caledonia, a very high incidence area (1985–1999). Eur J Cancer Prev 16(1):62–70

    Article  PubMed  Google Scholar 

  16. Truong T, Orsi L, Dubourdieu D, Rougier Y, Hemon D, Guenel P (2005) Role of goiter and of menstrual and reproductive factors in thyroid cancer: a population-based case-control study in New Caledonia (South Pacific), a very high incidence area. Am J Epidemiol 161(11):1056–1065

    Article  PubMed  Google Scholar 

  17. Guignard R, Truong T, Rougier Y, Baron-Dubourdieu D, Guenel P (2007) Alcohol drinking, tobacco smoking, and anthropometric characteristics as risk factors for thyroid cancer: a countrywide case-control study in New Caledonia. Am J Epidemiol 166(10):1140–1149

    Article  PubMed  Google Scholar 

  18. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH (1994) Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 86(21):1600–1608

    Article  PubMed  CAS  Google Scholar 

  19. Hemminki K, Vaittinen P (1999) Familial cancers in a nationwide family cancer database: age distribution and prevalence. Eur J Cancer 35(7):1109–1117

    Article  PubMed  CAS  Google Scholar 

  20. Hemminki K, Eng C, Chen B (2005) Familial risks for nonmedullary thyroid cancer. J Clin Endocrinol Metab 90(10):5747–5753

    Article  PubMed  CAS  Google Scholar 

  21. Kerber RA, O’Brien E (2005) A cohort study of cancer risk in relation to family histories of cancer in the Utah population database. Cancer 103(9):1906–1915

    Article  PubMed  Google Scholar 

  22. Frich L, Glattre E, Akslen LA (2001) Familial occurrence of nonmedullary thyroid cancer: a population-based study of 5673 first-degree relatives of thyroid cancer patients from Norway. Cancer Epidemiol Biomarkers Prev 10(2):113–117

    PubMed  CAS  Google Scholar 

  23. Hrafnkelsson J, Tulinius H, Jonasson JG, Sigvaldason H (2001) Familial non-medullary thyroid cancer in Iceland. J Med Genet 38(3):189–191

    Article  PubMed  CAS  Google Scholar 

  24. Galanti MR, Ekbom A, Grimelius L, Yuen J (1997) Parental cancer and risk of papillary and follicular thyroid carcinoma. Br J Cancer 75(3):451–456

    Article  PubMed  CAS  Google Scholar 

  25. Horn-Ross PL, Morris JS, Lee M, West DW, Whittemore AS, McDougall IR et al (2001) Iodine and thyroid cancer risk among women in a multiethnic population: the Bay Area Thyroid Cancer Study. Cancer Epidemiol Biomarkers Prev 10(9):979–985

    PubMed  CAS  Google Scholar 

  26. Ron E, Kleinerman RA, LiVolsi VA, Fraumeni JF Jr (1991) Familial nonmedullary thyroid cancer. Oncology 48(4):309–311

    Article  PubMed  CAS  Google Scholar 

  27. Mack WJ, Preston-Martin S, Bernstein L, Qian D (2002) Lifestyle and other risk factors for thyroid cancer in Los Angeles County females. Ann Epidemiol 12(6):395–401

    Article  PubMed  Google Scholar 

  28. Memon A, Berrington De Gonzalez A, Luqmani Y, Suresh A (2004) Family history of benign thyroid disease and cancer and risk of thyroid cancer. Eur J Cancer 40(5):754–760

  29. Brindel P, Doyon F, Bourgain C, Rachedi F, Boissin JL, Sebbag J et al (2010) Family history of thyroid cancer and the risk of differentiated thyroid cancer in French polynesia. Thyroid 20:393–400

    Article  PubMed  Google Scholar 

  30. Xu L, Li G, Wei Q, El-Naggar AK, Sturgis EM (2011) Family history of cancer and risk of sporadic differentiated thyroid carcinoma. Cancer 118(5):1228–1235

    Google Scholar 

  31. Adjadj E, Schlumberger M, de Vathaire F (2009) Germ-line DNA polymorphisms and susceptibility to differentiated thyroid cancer. Lancet Oncol 10(2):181–190

    Article  PubMed  CAS  Google Scholar 

  32. Gudmundsson J, Sulem P, Gudbjartsson DF, Jonasson JG, Sigurdsson A, Bergthorsson JT et al (2009) Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat Genet 41(4):460–464

    Article  PubMed  CAS  Google Scholar 

  33. R Development Core Team (2011) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN:3-900051-07-0. http://www.R-project.org

  34. Friedlaender JS, Friedlaender FR, Reed FA, Kidd KK, Kidd JR, Chambers GK et al (2008) The genetic structure of Pacific Islanders. PLoS Genet 4(1):e19

    Article  PubMed  Google Scholar 

  35. Pal T, Vogl FD, Chappuis PO, Tsang R, Brierley J, Renard H et al (2001) Increased risk for nonmedullary thyroid cancer in the first degree relatives of prevalent cases of nonmedullary thyroid cancer: a hospital-based study. J Clin Endocrinol Metab 86(11):5307–5312

    Article  PubMed  CAS  Google Scholar 

  36. Leprat F, Bonichon F, Guyot M, Trouette H, Trojani M, Vergnot V et al (1999) Familial non-medullary thyroid carcinoma: pathology review in 27 affected cases from 13 French families. Clin Endocrinol (Oxf) 50(5):589–594

    Article  CAS  Google Scholar 

  37. Loh KC (1997) Familial nonmedullary thyroid carcinoma: a meta-review of case series. Thyroid 7(1):107–113

    Article  PubMed  CAS  Google Scholar 

  38. Grossman RF, Tu SH, Duh QY, Siperstein AE, Novosolov F, Clark OH (1995) Familial nonmedullary thyroid cancer. An emerging entity that warrants aggressive treatment. Arch Surg 130(8):892–897; discussion 8–9

    Google Scholar 

  39. Lupoli G, Vitale G, Caraglia M, Fittipaldi MR, Abbruzzese A, Tagliaferri P et al (1999) Familial papillary thyroid microcarcinoma: a new clinical entity. Lancet 353(9153):637–639

    Article  PubMed  CAS  Google Scholar 

  40. Alsanea O, Wada N, Ain K, Wong M, Taylor K, Ituarte PH, et al. (2000) Is familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter series. Surgery 128(6):1043–1050; discussion 50–51

    Google Scholar 

  41. Uchino S, Noguchi S, Kawamoto H, Yamashita H, Watanabe S, Yamashita H et al (2002) Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population. World J Surg 26(8):897–902

    Article  PubMed  Google Scholar 

  42. Sippel RS, Caron NR, Clark OH (2007) An evidence-based approach to familial nonmedullary thyroid cancer: screening, clinical management, and follow-up. World J Surg 31(5):924–933

    Article  PubMed  Google Scholar 

  43. Triponez F, Wong M, Sturgeon C, Caron N, Ginzinger DG, Segal MR et al (2006) Does familial non-medullary thyroid cancer adversely affect survival? World J Surg 30(5):787–793

    Article  PubMed  Google Scholar 

  44. Maxwell EL, Hall FT, Freeman JL (2004) Familial non-medullary thyroid cancer: a matched-case control study. Laryngoscope 114(12):2182–2186

    Article  PubMed  Google Scholar 

  45. Mack WJ, Preston-Martin S, Bernstein L, Qian D, Xiang M (1999) Reproductive and hormonal risk factors for thyroid cancer in Los Angeles County females. Cancer Epidemiol Biomarkers Prev 8(11):991–997

    PubMed  CAS  Google Scholar 

  46. Horn-Ross PL, Canchola AJ, Ma H, Reynolds P, Bernstein L (2011) Hormonal factors and the risk of papillary thyroid cancer in the california teachers study cohort. Cancer Epidemiol Biomarkers Prev 20(8):1751–1759

    Article  PubMed  Google Scholar 

  47. Fagin JA (1997) Familial nonmedullary thyroid carcinoma—the case for genetic susceptibility. J Clin Endocrinol Metab 82(2):342–344

    Article  PubMed  CAS  Google Scholar 

  48. Burgess JR, Duffield A, Wilkinson SJ, Ware R, Greenaway TM, Percival J et al (1997) Two families with an autosomal dominant inheritance pattern for papillary carcinoma of the thyroid. J Clin Endocrinol Metab 82(2):345–348

    Article  PubMed  CAS  Google Scholar 

  49. Bignell GR, Canzian F, Shayeghi M, Stark M, Shugart YY, Biggs P et al (1997) Familial nontoxic multinodular thyroid goiter locus maps to chromosome 14q but does not account for familial nonmedullary thyroid cancer. Am J Hum Genet 61(5):1123–1130

    Article  PubMed  CAS  Google Scholar 

  50. Canzian F, Amati P, Harach HR, Kraimps JL, Lesueur F, Barbier J et al (1998) A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2. Am J Hum Genet 63(6):1743–1748

    Article  PubMed  CAS  Google Scholar 

  51. Malchoff CD, Sarfarazi M, Tendler B, Forouhar F, Whalen G, Joshi V et al (2000) Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumor syndrome. J Clin Endocrinol Metab 85(5):1758–1764

    Article  PubMed  CAS  Google Scholar 

  52. McKay JD, Lesueur F, Jonard L, Pastore A, Williamson J, Hoffman L et al (2001) Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21. Am J Hum Genet 69(2):440–446

    Article  PubMed  CAS  Google Scholar 

  53. He H, Nagy R, Liyanarachchi S, Jiao H, Li W, Suster S et al (2009) A susceptibility locus for papillary thyroid carcinoma on chromosome 8q24. Cancer Res 69(2):625–631

    Article  PubMed  CAS  Google Scholar 

  54. Lesueur F, Stark M, Tocco T, Ayadi H, Delisle MJ, Goldgar DE et al (1999) Genetic heterogeneity in familial nonmedullary thyroid carcinoma: exclusion of linkage to RET, MNG1, and TCO in 56 families. NMTC Consortium. J Clin Endocrinol Metab 84(6):2157–2162

    Article  PubMed  CAS  Google Scholar 

  55. Bevan S, Pal T, Greenberg CR, Green H, Wixey J, Bignell G et al (2001) A comprehensive analysis of MNG1, TCO1, fPTC, PTEN, TSHR, and TRKA in familial nonmedullary thyroid cancer: confirmation of linkage to TCO1. J Clin Endocrinol Metab 86(8):3701–3704

    Article  PubMed  CAS  Google Scholar 

  56. Cavaco BM, Batista PF, Martins C, Banito A, do Rosario F, Limbert E, et al. (2008) Familial non-medullary thyroid carcinoma (FNMTC): analysis of fPTC/PRN, NMTC1, MNG1 and TCO susceptibility loci and identification of somatic BRAF and RAS mutations. Endocr Relat Cancer 15(1):207–215

    Google Scholar 

  57. Truong T, Baron-Dubourdieu D, Rougier Y, Guenel P (2010) Role of dietary iodine and cruciferous vegetables in thyroid cancer: a countrywide case-control study in New Caledonia. Cancer Causes Control 21(8):1183–1192

    Google Scholar 

  58. Hemminki K, Li X (2002) Gender effects in familial cancer. Int J Cancer 102(2):184–187

    Article  PubMed  CAS  Google Scholar 

  59. Wingren G, Hatschek T, Axelson O (1993) Determinants of papillary cancer of the thyroid. Am J Epidemiol 138(7):482–491

    PubMed  CAS  Google Scholar 

  60. Paoff K, Preston-Martin S, Mack WJ, Monroe K (1995) A case-control study of maternal risk factors for thyroid cancer in young women (California, United States). Cancer Causes Control 6(5):389–397

    Article  PubMed  CAS  Google Scholar 

  61. Kolonel LN, Hankin JH, Wilkens LR, Fukunaga FH, Hinds MW (1990) An epidemiologic study of thyroid cancer in Hawaii. Cancer Causes Control 1(3):223–234

    Article  PubMed  CAS  Google Scholar 

  62. Preston-Martin S, Jin F, Duda MJ, Mack WJ (1993) A case-control study of thyroid cancer in women under age 55 in Shanghai (People’s Republic of China). Cancer Causes Control 4(5):431–440

    Article  PubMed  CAS  Google Scholar 

  63. D’Avanzo B, La Vecchia C, Franceschi S, Negri E, Talamini R (1995) History of thyroid diseases and subsequent thyroid cancer risk. Cancer Epidemiol Biomarkers Prev 4(3):193–199

    PubMed  Google Scholar 

  64. Hallquist A, Hardell L, Degerman A, Boquist L (1994) Thyroid cancer: reproductive factors, previous diseases, drug intake, family history and diet. A case-control study. Eur J Cancer Prev 3(6):481–488

    Article  PubMed  CAS  Google Scholar 

  65. Sokic SI, Adanja BJ, Vlajinac HD, Jankovic RR, Marinkovic JP, Zivaljevic VR (1994) Risk factors for thyroid cancer. Neoplasma 41(6):371–374

    PubMed  CAS  Google Scholar 

  66. Iribarren C, Haselkorn T, Tekawa IS, Friedman GD (2001) Cohort study of thyroid cancer in a San Francisco Bay area population. Int J Cancer 93(5):745–750

    Article  PubMed  CAS  Google Scholar 

  67. Levi F, Franceschi S, La Vecchia C, Negri E, Gulie C, Duruz G et al (1991) Previous thyroid disease and risk of thyroid cancer in Switzerland. Eur J Cancer 27(1):85–88

    Article  PubMed  CAS  Google Scholar 

  68. Franceschi S, Preston-Martin S, Dal Maso L, Negri E, La Vecchia C, Mack WJ, et al. (1999) A pooled analysis of case-control studies of thyroid cancer. IV. Benign thyroid diseases. Cancer Causes Control 10(6):583–595

    Google Scholar 

  69. Kerber RA, Slattery ML (1997) Comparison of self-reported and database-linked family history of cancer data in a case-control study. Am J Epidemiol 146(3):244–248

    Article  PubMed  CAS  Google Scholar 

  70. Soegaard M, Jensen A, Frederiksen K, Hogdall E, Hogdall C, Blaakaer J et al (2008) Accuracy of self-reported family history of cancer in a large case-control study of ovarian cancer. Cancer Causes Control 19(5):469–479

    Article  PubMed  Google Scholar 

  71. Mitchell RJ, Brewster D, Campbell H, Porteous ME, Wyllie AH, Bird CC et al (2004) Accuracy of reporting of family history of colorectal cancer. Gut 53(2):291–295

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported by grants from the “Fondation de France,” the “Association pour la Recherche contre le Cancer,” and the “Agence Française de Sécurité Sanitaire de l’Environnement et du Travail (AFSSET).” The authors wish to thank Dr Jean-Paul Grangeon (Direction des Affaires Sanitaires et Sociales Nouvelle-Calédonie) as well as the Provincial Health Authorities (DPASS Sud, DPASS Nord, DPASS Îles) for their support during data collection. They are particularly grateful to Michèle Reynier who coordinated the interviews of study subjects across New Caledonia.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pascal Guénel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leux, C., Truong, T., Petit, C. et al. Family history of malignant and benign thyroid diseases and risk of thyroid cancer: a population-based case–control study in New Caledonia. Cancer Causes Control 23, 745–755 (2012). https://doi.org/10.1007/s10552-012-9944-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10552-012-9944-7

Keywords

Navigation